Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J-E Gottenberg
FRI0221 Does Seropositivity Influence Differentially Drug Discontinuation of Biologic Antirheumatic Agents With Non-Anti-TNF Mode of Action?
Prevalence of Anti-Cyclic Citrullinated Peptide and Anti-Keratin Antibodies in Patients With Primary Sjogren's Syndrome
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
THU0174 Drug Retention of Tofacitinib Versus Biologic Antirheumatic Agents in Rheumatoid Arthritis: Observational Data From the Swiss SCQM Registry
Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients With Rheumatoid Arthritis
Genes
Genetics
FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis
Studies on the Mode of Action of Non-Steroid Anti-Inflammatory Drugs.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
High Incidence of Disease Recurrence After Discontinuation of Disease-Modifying Antirheumatic Drug Treatment in Patients With Psoriatic Arthritis in Remission
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Site of Analgesic (Anti-Writhing) Action of a Non-Steroidal Anti-Inflammatory Drug, Tolmetin Sodium
Ensho
Editorial: Therapeutic Drug Monitoring for Anti-TNF Agents-Has It All Been Said? Author's Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Genetic Markers Predict Primary Non-Response and Durable Response to Anti-TNF Biologic Therapies in Crohn’s Disease
American Journal of Gastroenterology
Hepatology
Gastroenterology
AB1031 Anti-Drug Antibodies: Assay Performance in Patients Treated With ANTI-TNF Biodrugs
